Lidocaïne/Adrenaline Aguettant

Lidocaine hydrochloride, the active ingredient in Lidocaïne/Adrenaline Aguettant, is a local anesthetic presented as a sterile solution for epidural, infiltration and perineural use. It provides rapid onset numbness and, when combined with epinephrine, prolongs the anesthetic effect while reducing systemic absorption.

GNH USA supplies Lidocaïne/Adrenaline Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine hydrochloride and epinephrine act on peripheral nerves and vascular smooth muscle to provide localized anesthesia and vasoconstriction. - Minor surgical procedures: enables painless incision and tissue manipulation. - Epidural anesthesia: delivers sustained sensory block for obstetric or abdominal surgery. - Peripheral nerve block (perineural use): facilitates regional anesthesia for limb surgeries. - Infiltration anesthesia: provides local numbness for dermatologic or dental interventions.

Adverse reactions may occur following administration of the lidocaine‑epinephrine combination.

Common Side Effects: - Injection site pain or burning sensation - Transient dizziness or light‑headedness - Mild hypotension or tachycardia - Nausea or vomiting - Localized swelling or erythema - Headache

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Cardiac arrhythmias, including ventricular tachycardia - Allergic reactions such as urticaria or anaphylaxis - Seizures or central nervous system toxicity - Cardiac arrest - Methemoglobinemia (rare)

When using Lidocaïne/Adrenaline Aguettant, clinicians should observe several safety measures. - Allergy assessment: verify no known hypersensitivity to lidocaine or epinephrine. - Cardiovascular monitoring: observe heart rate and blood pressure during and after injection. - Dose minimization: use the lowest effective volume to achieve anesthesia. - Hypertension caution: avoid in patients with uncontrolled high blood pressure. - Drug interaction review: consider concomitant beta‑blockers or MAO inhibitors. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Lidocaine‑epinephrine may interact with several drug classes, altering cardiovascular or neurologic responses.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol): can exacerbate bradycardia and hypotension. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis. - Tricyclic antidepressants: may potentiate lidocaine toxicity. - Other vasoconstrictors (e.g., phenylephrine): additive hypertension. - Class I anti‑arrhythmic agents: heightened arrhythmia risk.

Moderate Interactions (Monitor Closely): - Alpha‑adrenergic agonists (e.g., clonidine): may affect blood pressure control. - Diuretics: alter plasma electrolyte balance influencing lidocaine levels. - Anticoagulants: increased bleeding risk if vasoconstriction is insufficient. - Other local anesthetics: cumulative toxicity potential. - Calcium channel blockers: possible additive cardiac effects.